HomeLIMN • NASDAQ
add
Liminatus Pharma Inc
Previous close
$0.95
Day range
$0.71 - $0.99
Year range
$0.61 - $33.66
Market cap
22.78M USD
Avg Volume
385.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 701.17K | 29.09% |
Net income | -1.82M | -203.20% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -700.63K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 724.50K | 1,441.49% |
Total assets | 1.34M | -70.24% |
Total liabilities | 2.99M | -87.35% |
Total equity | -1.65M | — |
Shares outstanding | 27.06M | — |
Price to book | -15.88 | — |
Return on assets | -107.83% | — |
Return on capital | 46.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.82M | -203.20% |
Cash from operations | -600.61K | -191.39% |
Cash from investing | -13.11K | 98.36% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -613.72K | -4,864.54% |
Free cash flow | -8.15M | — |
About
Headquarters
Website
